KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Other Non Operating Income (2016 - 2025)

Jazz Pharmaceuticals has reported Other Non Operating Income over the past 16 years, most recently at -$658000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$658000.0 for Q4 2025, up 89.55% from a year ago — trailing twelve months through Dec 2025 was -$8.6 million (down 5.72% YoY), and the annual figure for FY2025 was -$2.6 million, up 68.61%.
  • Other Non Operating Income for Q4 2025 was -$658000.0 at Jazz Pharmaceuticals, down from $102000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for JAZZ hit a ceiling of $9.4 million in Q4 2023 and a floor of -$10.5 million in Q1 2022.
  • Median Other Non Operating Income over the past 5 years was -$1.4 million (2023), compared with a mean of -$1.3 million.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 735.78% in 2021 and later crashed 1217.71% in 2022.
  • Jazz Pharmaceuticals' Other Non Operating Income stood at -$5.6 million in 2021, then soared by 55.77% to -$2.5 million in 2022, then soared by 476.83% to $9.4 million in 2023, then crashed by 167.3% to -$6.3 million in 2024, then surged by 89.55% to -$658000.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$658000.0 (Q4 2025), $102000.0 (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.